Bone mineral density in adults with Down syndrome
- 264 Downloads
- 1 Citations
Abstract
Summary
This study analyzed data of bone mineral density (BMD) from a large cohort of adults with Down syndrome (DS). BMD was found to decrease with age more rapidly in these subjects than in the general population, exposing adults with DS to an increased risk of osteoporosis and bone fracture.
Introduction
Down syndrome (DS) in adulthood presents with a high prevalence of osteoporosis. However, in DS, bone mineral density (BMD) can be underestimated due to short stature. Furthermore, the rate of age-related decline in BMD and its association with gender in DS has been rarely evaluated or compared with the general population. The present study is aimed at assessing the variation of BMD with age and gender in a sample of adults with DS and to compare these data with those of the general population, after adjusting for anthropometric differences.
Methods
Adults with DS, aged 18 or older, were assessed dual-energy-X-ray-absorptiometry (DXA) at the femoral neck and at the lumbar spine. They were compared with the general population enrolled in the National Health and Nutrition Examination Survey (NHANES) 2009–2010 dataset. Bone mineral apparent density (BMAD) was calculated for each individual.
Results
DXA was evaluated in 234 subjects with DS (mean age 36.93 ± 11.83 years, ranging from 20 to 69 years; 50.4% females). In the lumbar spine both mean BMD (DS 0.880 ± 0.141 vs. NHANES 1.062 ± 0.167, p < 0.001) and BMAD (DS 0.138 ± 0.020 vs. NHANES 0.152 ± 0.020, p < 0.001) were significantly lower in the DS sample than in the NAHNES cohort. The same trend was observed at the femoral neck in both BMD (DS 0.658 ± 0.128 vs. NHANES 0.835 ± 0.137, p < 0.001) and BMAD (DS 0.151 ± 0.030 vs. NHANES 0.159 ± 0.028, p<0.001). Age was associated with lower femoral neck BMAD in both samples; importantly, this association was significantly stronger in the DS sample. In the lumbar spine region, no significant association between BMAD and age could be observed in both samples.
Conclusions
Adults with DS have lower bone mineral density compared to the general population and they experience a steeper decline with age. Early screening programs are needed in DS population.
Keywords
Aging Bone Down syndrome OsteoporosisNotes
Acknowledgments
We gratefully thank the contribution of Alex Sisto for the critical review of the text.
Compliance with ethical standards
Conflict of interest
None.
References
- 1.Loane M, Morris JK, Addor M-C, Arriola L, Budd J, Doray B, Garne E, Gatt M, Haeusler M, Khoshnood B, Klungsøyr Melve K, Latos-Bielenska A, McDonnell B, Mullaney C, O’Mahony M, Queißer-Wahrendorf A, Rankin J, Rissmann A, Rounding C, Salvador J, Tucker D, Wellesley D, Yevtushok L, Dolk H (2012) Twenty-year trends in the prevalence of Down syndrome and other trisomies in Europe: impact of maternal age and prenatal screening. doi: 10.1038/ejhg.2012.94
- 2.Bittles AH, Glasson EJ (2004) Clinical, social, and ethical implications of changing life expectancy in Down syndrome. Dev Med Child Neurol 46:282–286CrossRefPubMedGoogle Scholar
- 3.Martin GM (1978) Genetic syndromes in man with potential relevance to the pathobiology of aging. Birth Defects Orig Artic Ser 14:5–39PubMedGoogle Scholar
- 4.Carfì A, Antocicco M, Brandi V, Cipriani C, Fiore F, Mascia D, Settanni S, Vetrano DL, Bernabei R, Onder G (2014) Characteristics of adults with Down syndrome: prevalence of age-related conditions. Front Med. doi: 10.3389/fmed.2014.00051
- 5.Carfì A, Brandi V, Zampino G, Mari D, Onder G (2015) Editorial: care of adults with Down syndrome: gaps and needs. Eur J Intern Med. doi: 10.1016/j.ejim.2015.04.018
- 6.Vetrano DL, Carfì A, Brandi V, L’Angiocola PD, Di Tella S, Cipriani MC, Antocicco M, Zuccalà G, Palmieri V, Silveri MC, Bernabei R, Onder G (2015) Left ventricle diastolic function and cognitive performance in adults with Down syndrome. Int J Cardiol. doi: 10.1016/j.ijcard.2015.11.041
- 7.Angelopoulou N, Souftas V, Sakadamis A, Mandroukas K (1999) Bone mineral density in adults with Down’s syndrome. Eur Radiol 9:648–651CrossRefPubMedGoogle Scholar
- 8.Baptista F, Varela A, Sardinha LB (2005) Bone mineral mass in males and females with and without Down syndrome. Osteoporos Int 16:380–388. doi: 10.1007/s00198-004-1687-1 CrossRefPubMedGoogle Scholar
- 9.Geijer JR, Stanish HI, Draheim CC, Dengel DR (2014) Bone mineral density in adults with Down syndrome, intellectual disability, and nondisabled adults. Am J Intellect Dev Disabil 119:107–114. doi: 10.1352/1944-7558-119.2.107 CrossRefPubMedGoogle Scholar
- 10.García-Hoyos M, García-Unzueta MT, de Luis D, Valero C, Riancho JA (2017) Diverging results of areal and volumetric bone mineral density in Down syndrome. Osteoporos Int 28:965–972. doi: 10.1007/s00198-016-3814-1 CrossRefPubMedGoogle Scholar
- 11.Prentice A, Parsons TJ, Cole TJ (1994) Uncritical use of bone mineral density in absorptiometry may lead to size-related artifacts in the identification of bone mineral determinants. Am J Clin Nutr 60:837–842PubMedGoogle Scholar
- 12.Lu PW, Cowell CT, LLoyd-Jones SA, Briody JN, Howman-Giles R (1996) Volumetric bone mineral density in normal subjects, aged 5–27 years. J Clin Endocrinol Metab 81:1586–1590. doi: 10.1210/jcem.81.4.8636372
- 13.Katzman DK, Bachrach LK, Carter DR, Marcus R (1991) Clinical and anthropometric correlates of bone mineral acquisition in healthy adolescent girls. J Clin Endocrinol Metab 73:1332–1339. doi: 10.1210/jcem-73-6-1332 CrossRefPubMedGoogle Scholar
- 14.Blazek JD, Gaddy A, Meyer R, Roper RJ, Li J (2011) Disruption of bone development and homeostasis by trisomy in Ts65Dn Down syndrome mice. Bone 48:275–280. doi: 10.1016/j.bone.2010.09.028 CrossRefPubMedGoogle Scholar
- 15.Grimwood JS, Kumar A, Bickerstaff DR, Suvarna SK (2000) Histological assessment of vertebral bone in a Down’s syndrome adult with osteoporosis. Histopathology 36:279–280CrossRefPubMedGoogle Scholar
- 16.Fowler TW, McKelvey KD, Akel NS, Vander Schilden J, Bacon AW, Bracey JW, Sowder T, Skinner R a., Swain FL, Hogue WR, Leblanc DB, Gaddy D, Wenger GR, Suva LJ (2012) Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment. PLoS One 7:e42967. doi: 10.1371/journal.pone.0042967
- 17.McKelvey KD, Fowler TW, Akel NS, Kelsay J a, Gaddy D, Wenger GR, Suva LJ (2013) Low bone turnover and low bone density in a cohort of adults with Down syndrome. Osteoporos Int 24:1333–1338. doi: 10.1007/s00198-012-2109-4
- 18.Looker AC, Melton LJ, Borrud LG, Shepherd JA (2012) Lumbar spine bone mineral density in US adults: demographic patterns and relationship with femur neck skeletal status. Osteoporos Int 23:1351–1360. doi: 10.1007/s00198-011-1693-z CrossRefPubMedGoogle Scholar
- 19.Hawli Y, Nasrallah M, El-Hajj Fuleihan G (2009) Endocrine and musculoskeletal abnormalities in patients with Down syndrome. Nat Rev Endocrinol 5:327–334. doi: 10.1038/nrendo.2009.80 CrossRefPubMedGoogle Scholar
- 20.Villani ER, Carfì A, Pagano F, Raimondo S, Di Segni C, Onder G, Mancini A (2014) Relationships among androgens, osteocalcin and low bone mass density in a cohort of adults with Down syndrome. G Ital di Ostet e Ginecol 36:599–602Google Scholar